HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abdolmohamad Rostami Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

1/2022CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
1/2022Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells.
1/2021Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.
1/2021IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells.
10/2020A distinct GM-CSF+ T helper cell subset requires T-bet to adopt a TH1 phenotype and promote neuroinflammation.
1/2020Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor-producing Th1 cells in CNS neuroinflammation.
1/2019Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism.
1/2018Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.
1/2018Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4+ CD127+3G11+ Regulatory T Cell Subset.
1/2017LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abdolmohamad Rostami Research Topics

Disease

64Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 03/2002
39Multiple Sclerosis
02/2022 - 11/2003
29Inflammation (Inflammations)
01/2022 - 08/2002
24Autoimmune Diseases (Autoimmune Disease)
11/2020 - 11/2003
20Demyelinating Diseases (Demyelinating Disease)
01/2020 - 12/2002
12Neuroinflammatory Diseases
02/2022 - 01/2016
4Optic Neuritis (Retrobulbar Neuritis)
12/2010 - 08/2007
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 12/2009
3Neoplasms (Cancer)
12/2021 - 12/2011
2Rheumatoid Arthritis
01/2020 - 01/2019
2Gliosis
01/2017 - 02/2014
1Allergic Rhinitis
01/2021
1Asthma (Bronchial Asthma)
01/2021
1Bites and Stings (Sting)
12/2020
1Tremor (Tremors)
01/2019
1Chronic Disease (Chronic Diseases)
12/2017
1Acute Disease
01/2017
1Encephalomyelitis (Myeloencephalitis)
01/2016
1Disease Progression
11/2015
1Paralysis (Palsy)
01/2013
1Thymoma (Thymic Carcinoma)
09/2012
1Communicable Diseases (Infectious Diseases)
12/2011
1Starvation
11/2010

Drug/Important Bio-Agent (IBA)

14CytokinesIBA
01/2020 - 01/2004
11Interleukin-23 (Interleukin 23)IBA
03/2020 - 02/2003
10Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021 - 06/2011
10Interleukin-12 (IL 12)IBA
10/2020 - 03/2002
10Peptides (Polypeptides)IBA
01/2016 - 08/2002
8Therapeutic UsesIBA
02/2022 - 12/2005
8AutoantigensIBA
11/2020 - 03/2002
8Interleukin-27 (Interleukin 27)IBA
01/2018 - 05/2005
7AntigensIBA
11/2020 - 12/2007
7Interleukin-10 (Interleukin 10)IBA
01/2016 - 12/2007
6Interleukin-17 (Interleukin 17)IBA
04/2013 - 12/2007
5Interleukin-9 (Interleukin 9)IBA
01/2020 - 06/2010
5Myelin-Oligodendrocyte GlycoproteinIBA
01/2016 - 03/2004
3Interleukin-12 Receptors (Interleukin 12 Receptor)IBA
06/2012 - 02/2003
2Biological ProductsIBA
01/2020 - 06/2010
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2019 - 01/2017
2Calcitriol (Calcijex)FDA LinkGeneric
01/2017 - 04/2015
2Galectin 1 (LGALS1)IBA
01/2016 - 08/2013
2InterleukinsIBA
12/2015 - 12/2007
2AntibodiesIBA
09/2013 - 03/2004
2ResveratrolIBA
12/2010 - 08/2007
2Sirtuin 1IBA
12/2010 - 08/2007
2Proteins (Proteins, Gene)FDA Link
03/2010 - 08/2007
2denileukin diftitox (Ontak)FDA Link
01/2010 - 12/2007
2Interleukin-23 Subunit p19IBA
02/2007 - 11/2003
1Pharmaceutical PreparationsIBA
02/2022
1KynurenineIBA
02/2022
1Drinking WaterIBA
01/2022
1Mannose (D-Mannose)IBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Macrophage Colony-Stimulating FactorIBA
01/2022
1LeukotrienesIBA
01/2021
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
01/2021
1montelukast (Singulair)FDA Link
01/2021
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2021
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
12/2020
1PrimaquineFDA Link
11/2020
1InterferonsIBA
10/2020
1Chloroquine (Aralen)FDA LinkGeneric
06/2020
1VaccinesIBA
05/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2020
1CuprizoneIBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Ursolic AcidIBA
01/2020
1Dimethyl FumarateIBA
01/2020
1Am 580 (Am580)IBA
01/2019
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2019
1Interleukin-2 (IL2)IBA
12/2017
1Carrier Proteins (Binding Protein)IBA
01/2016
1Polysaccharides (Glycans)IBA
01/2016
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2015
1baicalinIBA
11/2015
1CDw17 antigen (lactosylceramide)IBA
10/2014
1Interferon Regulatory FactorsIBA
07/2014
1Interleukin-4 (Interleukin 4)IBA
10/2013
1Interleukin-17 ReceptorsIBA
04/2013
1ZymosanIBA
01/2013
1Protease Inhibitors (Protease Inhibitor)IBA
12/2012
1Serine Proteases (Serine Protease)IBA
12/2012
1DNA (Deoxyribonucleic Acid)IBA
09/2012
1Amino AcidsFDA Link
11/2010
1halofuginoneIBA
11/2010
1Tryptophan (L-Tryptophan)FDA Link
11/2010
1Phosphotransferases (Kinase)IBA
11/2010
1GangliosidesIBA
10/2010
1EpitopesIBA
10/2010
1Transcription Factors (Transcription Factor)IBA
06/2010
1Imiquimod (Aldara)FDA LinkGeneric
04/2010
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2010
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2010

Therapy/Procedure

27Therapeutics
02/2022 - 08/2007
7Immunomodulation
05/2020 - 08/2007
3Immunotherapy
12/2021 - 08/2008
3Transplantation
01/2017 - 10/2010
2Intravenous Administration
08/2015 - 03/2002
1Aftercare (After-Treatment)
03/2010